The 2024 Alzheimer’s Association’s International Conference (AAIC) annual conference (https://aaic.alz.org/) will take place July 28 – August 1, 2024 in Philadelphia, PA.
The NGI Center is represented by 11 of our own researchers who are showcasing their recent work on Alzheimer’s disease either through oral presentations, guided poster tours, and posters. The contributions to this year’s conference stretches across many “omic” approaches to identify risk factors, biomarkers, and drug targets that will help progress the field of neurodegenerative disease study.
We would like to recognize the hard work done by each of our presenters. The presenters and the title of their talks and posters are listed below:
- Gyujin Heo
Oral presentation 7/31, 2:00pm-3:30pmCT
Large-scale Plasma Proteomic Profiling Identifies a Robust Set of Biomarkers for Detection of Clinical Alzheimer’s Disease - Ciyang Wang
Oral Presentation 7/30, 9:00am-10:30amCT
Multi-tissue metabolomics analyses identify disrupted processes in Alzheimer’s Disease - Yun Ju Sung
Oral presentation 7/31, 2:00pm-3:30pmCT
Sex-specific genetic regulation of proteomics in cerebrospinal fluid uncovers genetic causes for sex differences in neurodegeneration - Carlos Cruchaga
Oral presentation 7/29, 9:00-10:30am
Multi-tissue multi-omic trans QTL mapping identified novel causal and druggable targets and gene-gene interactions - Laura Ibanez
Oral Presentation 7/28, 9:00-10:30am
Impact of gantenerumab amyloid removal therapy on established Alzheimer Disease fluid biomarkers - Daniel Western
Poster 7/30
Integration of GWAS and cerebrospinal fluid proteogenomics identifies proteins for AD and shared dysregulated mechanisms in other neurological traits - Maulikkumar Patel
Poster 7/30
Identification of genetic risk factors for brain amyloid deposition - Chengran Yang
Poster 7/28
Genetic analyses of the plasma proteome and metabolome from the same cohort pinpoint AD risk associated molecular phenotypes - Muhammad Ali
Poster 7/28
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease - Michael Belloy
Poster 7/28
Trans-ancestry GWAS for Alzheimer’s Disease Reveals a Novel Locus interacting with APOE*4
Poster 7/30, and Guided Poster Tour, 7/31: 3:30pm-4:15pm
Sex-stratified GWAS for Alzheimer’s Disease Reveals African Ancestry Risk variants in Men
Poster 7/30
The X Chromosome in Alzheimer’s Disease
Poster 7/31
The X-chromosome in Alzheimer’s disease genetics, stratified by APOE*4 and sex.
- Danielle Reid
Poster 7/30
Sex-Specific Causal Genes for Alzheimer’s Disease via Proteome-Wide Association Studies
